Top Markets
Coin of the day
Predictive Technology Group, Inc. Predictive Technology Group, Inc.

Predictive Technology Group, Inc.

PRED
株式のランク #41305
Predictive Technology Group, Inc. (PRED), along with its affiliated companies,... Predictive Technology Group, Inc. (PRED), along with its affiliated companies, specializes in the creation and market introduction of cutting-edge molecular diagnostic and therapeutic solutions, as well as human cellular and tissue-based products (HCT/Ps). The company's operations are divided into two primary segments: Human Cellular and Tissue Products (HCT/Ps), and Diagnostics and Therapeutics. PRED offers genetic testing services like FertilityDX, which assists couples experiencing infertility, and ARTguide, a genetic test for women struggling with infertility often linked to endometriosis and other genetic conditions. In the realm of regenerative medicine, its product offerings include AmnioCyte, AmnioCyte Plus, PolyCyte, and CoreCyte. Furthermore, Predictive Technology Group has a cooperative arrangement with Atrin Pharmaceuticals LLC to advance molecular diagnostic tools, which are intended to refine the selection of patients for cancer treatments. Founded in 2005, the company initially operated under the name Global Enterprises Group, Inc., before rebranding to Predictive Technology Group, Inc. in July 2015. Its corporate headquarters are situated in Salt Lake City, Utah.
株価
$0.0001
最終同期: 2024-12-31
時価総額
$28.10K
変化(1日)
0.00%
変化(1年)
0.00%
US
取引 Predictive Technology Group, Inc. (PRED)

カテゴリー

Predictive Technology Group, Inc.(PRED)のP/B比率
2026 時点のP/B比率 TTM: 0
Predictive Technology Group, Inc. の最新の財務報告および株価によると、現在のP/B比率(TTM)は 0 です。2026 年末時点でのP/B比率は 0 でした。
Predictive Technology Group, Inc. の P/B 比率の履歴(2026 ~ 2026)
各年末時点のP/B比率
P/B比率 変化
提供された日付のデータは十分ではありません。
同業他社のP/B比率
企業 P/B比率 P/B比率の差
6.2613 -
US
6.3483 -
NL
- -
CH
- -
KR
3.634 -
BE